4.7 Article

Click Biotinylation of PLGA Template for Biotin Receptor Oriented Delivery of Doxorubicin Hydrochloride in 4T1 Cell-Induced Breast Cancer

Journal

MOLECULAR PHARMACEUTICS
Volume 14, Issue 8, Pages 2749-2765

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.7b00310

Keywords

nanoparticles; common ion effect; PLGA; doxorubicin hydrochloride; click chemistry; active targeting

Funding

  1. DBT [BT/PR14769/NNT/28/996/2015]

Ask authors/readers for more resources

PLGA was functionalized with PEG and biotin using click chemistry to generate a biotin receptor tatgeted copolymer (biotinylated PEG-PLGA) which in turn was used to fabricate ultrafine nanoparticles (BPNP) of doxorubicin hydrochloride (DOX) for effective delivery in 4T1 cell induced breast cancer. However; adequate entrapment of a, hydrophilic bioactive like DOX in a hydrophobic polymer system made of PLGA is not usually possible. We therefote modified a conventional W/O/W emulsion method by utilizing NH4Cl in the external phase to constrain DOX in dissolved polymer phase by suppressing DOX's inherent, aqueous Solubility as per common ion effect. This resulted in over 8-fold enhancement in entrapment efficiency of DOX inside BPNP, which otherwise is highly susceptible to leakage due to its relatively high aqueous solubility. TEM and DLS established BPNP to be sized below 100 nm, storage stability studies showed that BPNP were stable for one month at 4 degrees C, and in vitro release suggested significant control in drug release. Extensive in vitro and in vivo studies were conducted to propound anticancer and antiproliferative activity of BPNP. Plasma and tissue distribution study supplemented by pertinent in vivo fluorescence imaging mapped the exact fate of DOX contained inside BPNP once it was administered intravenously. A comparative safety profile via acute toxicity studies in mice was also generated to out rightly establish usefulness of BPNP. Results suggest that BPNP substantially enhance anticancer activity of DOX while simultaneously mitigating its toxic potential due to altered spatial and temporal presentation of drug and consequently deserve further allometric iteration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Chetomin induces apoptosis in human triple-negative breast cancer cells by promoting calcium overload and mitochondrial dysfunction

Jayant Dewangan, Sonal Srivastava, Sakshi Mishra, Prabhash Kumar Pandey, Aman Divakar, Srikanta Kumar Rath

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Cell Biology

International conference on Cell Death in Cancer and Toxicology 2018 (CDCT-2018)

Kausar M. Ansari, Praveen R. Arany, Eli Arama, Sarit Larisch, Raymond B. Birge, Dhyan Chandra

CELL COMMUNICATION AND SIGNALING (2018)

Article Medicine, Research & Experimental

Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis

Jayant Dewangan, Shweta Kaushik, Srikanta Kumar Rath, Anil K. Balapure

LIFE SCIENCES (2018)

Article Neurosciences

Sneaky Entry of IFN Through Arsenic-Induced Leaky Blood-Brain Barrier Reduces CD200 Expression by Microglial pro-Inflammatory Cytokine

Vikas Singh, Shaivya Kushwaha, Ruchi Gera, Jamal Ahmad Ansari, Juhi Mishra, Jayant Dewangan, Satyakam Patnaik, Debabrata Ghosh

MOLECULAR NEUROBIOLOGY (2019)

Article Pathology

miRNA genetic variants: As potential diagnostic biomarkers for oral cancer

Divya Tandon, Jayant Dewangan, Sonal Srivastava, Vivek Kumar Garg, Srikanta Kumar Rath

PATHOLOGY RESEARCH AND PRACTICE (2018)

Article Biochemistry & Molecular Biology

Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin

Vivek K. Pawar, Yuvraj Singh, Komal Sharma, Arpita Shrivastav, Abhisheak Sharma, Akhilesh Singh, Jaya Gopal Meher, Pankaj Singh, Kavit Raval, Animesh Kumar, Himangshu K. Bora, Dipak Datta, Jawahar Lal, Manish K. Chourasia

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)

Article Chemistry, Multidisciplinary

Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis

Dhadhang Wahyu Kurniawan, Arun Kumar Jajoriya, Garima Dhawan, Divya Mishra, Josepmaria Argemi, Ramon Bataller, Gert Storm, Durga Prasad Mishra, Jai Prakash, Ruchi Bansal

JOURNAL OF CONTROLLED RELEASE (2018)

Correction Neurosciences

Sneaky Entry of IFN Through Arsenic-Induced Leaky Blood-Brain Barrier Reduces CD200 Expression by Microglial pro-Inflammatory Cytokine (vol 56, pg 1488, 2019)

Vikas Singh, Shaivya Kushwaha, Ruchi Gera, Jamal Ahmad Ansari, Juhi Mishra, Jayant Dewangan, Satyakam Patnaik, Debabrata Ghosh

MOLECULAR NEUROBIOLOGY (2019)

Article Biotechnology & Applied Microbiology

Paclitaxel-loaded TPGS enriched self-emulsifying carrier causes apoptosis by modulating survivin expression and inhibits tumour growth in syngeneic mammary tumours

Jaya Gopal Meher, Shivani Dixit, Darshad Khan Pathan, Yuvraj Singh, Hardik Chandasana, Vivek K. Pawar, Mani Sharma, Rabi Sankar Bhatta, Rituraj Konwar, Prashant Kesharwani, Manish K. Chourasia

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)

Meeting Abstract Gastroenterology & Hepatology

Survivin aggravates fibrogenecity of hepatic stellate cells via mediating TGF-beta/PI3K/Akt pathway

Arun Kumar Jajoriya, Jaspreet Bagga, Abhishek Nirwan, Durga Prasad Mishra

JOURNAL OF HEPATOLOGY (2019)

Article Medicine, Research & Experimental

Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate

Yuvraj Singh, K. K. Durga Rao Viswanadham, Vivek K. Pawar, Jayagopal Meher, Arun Kumar Jajoriya, Ankur Omer, Swati Jaiswal, Jayant Dewangan, H. K. Bora, Poonam Singh, Srikanta Kumar Rath, Jawahar Lal, Durga Prasad Mishra, Manish Kumar Chourasia

MOLECULAR PHARMACEUTICS (2019)

Article Gastroenterology & Hepatology

Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development

Tongqi Qian, Naoto Fujiwara, Bhuvaneswari Koneru, Atsushi Ono, Naoto Kubota, Arun K. Jajoriya, Matthew G. Tung, Emilie Crouchet, Won-Min Song, Cesia Ammi Marquez, Gayatri Panda, Ayaka Hoshida, Indu Raman, Quan-Zhen Li, Cheryl Lewis, Adam Yopp, Nicole E. Rich, Amit G. Singal, Shigeki Nakagawa, Nicolas Goossens, Takaaki Higashi, Anna P. Koh, C. Billie Bian, Hiroki Hoshida, Parissa Tabrizian, Ganesh Gunasekaran, Sander Florman, Myron E. Schwarz, Spiros P. Hiotis, Takashi Nakahara, Hiroshi Aikata, Eisuke Murakami, Toru Beppu, Hideo Baba, Rew Warren, Sangeeta Bhatia, Masahiro Kobayashi, Hiromitsu Kumada, Austin J. Fobar, Neehar D. Parikh, Jorge A. Marrero, Steve Hategekimana Rwema, Venugopalan Nair, Manishkumar Patel, Seunghee Kim-Schulze, Kathleen Corey, Jacqueline G. O'Leary, Goran B. Klintmalm, David L. Thomas, Mohammed Dibas, Gerardo Rodriguez, Bin Zhang, Scott L. Friedman, Thomas F. Baumert, Bryan C. Fuchs, Kazuaki Chayama, Shijia Zhu, Raymond T. Chung, Yujin Hoshida

Summary: This study developed a surrogate biomarker to predict liver fibrosis progression and evaluated the effectiveness of antifibrotic drugs. Results showed that a 20-gene surrogate biomarker could accurately predict fibrosis progression within 5 years. Furthermore, rational combination therapies based on epigallocatechin gallate were identified and validated for enhanced antifibrotic effect. This biomarker has potential clinical significance for the development of antifibrotics.

GASTROENTEROLOGY (2022)

Article Cell Biology

Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

Naoto Fujiwara, Naoto Kubota, Emilie Crouchet, Bhuvaneswari Koneru, Cesia A. Marquez, Arun K. Jajoriya, Gayatri Panda, Tongqi Qian, Shijia Zhu, Nicolas Goossens, Xiaochen Wang, Shuang Liang, Zhenyu Zhong, Sara Lewis, Bachir Taouli, Myron E. Schwartz, Maria Isabel Fiel, Amit G. Singal, Jorge A. Marrero, Austin J. Fobar, Neehar D. Parikh, Indu Raman, Quan-Zhen Li, Masataka Taguri, Atsushi Ono, Hiroshi Aikata, Takashi Nakahara, Hayato Nakagawa, Yuki Matsushita, Ryosuke Tateishi, Kazuhiko Koike, Masahiro Kobayashi, Takaaki Higashi, Shigeki Nakagawa, Yo-ichi Yamashita, Toru Beppu, Hideo Baba, Hiromitsu Kumada, Kazuaki Chayama, Thomas F. Baumert, Yujin Hoshida

Summary: This study analyzed multiple cohorts of NAFLD patients globally to define and validate signatures predictive of long-term HCC risk in NAFLD patients. These signatures can accurately predict the risk of developing HCC in patients and provide assistance for clinical treatment.

SCIENCE TRANSLATIONAL MEDICINE (2022)

No Data Available